Abstract Anaesthesia is a multivariable problem where a combination of drugs are used to induce desired hypnotic, analgesia and immobility states. The automation of anaesthesia may improve the safety and cost-effectiveness of anaesthesia. However, the realization of a safe and reliable multivariable closed-loop control of anaesthesia is yet to be achieved due to a manifold of challenges. In this paper, several significant challenges in automation of anaesthesia are discussed, namely model uncertainty, controlled variables, closed-loop application and dependability. The increasingly reliable measurement device, robust and adaptive controller, and better fault tolerance strategy are paving the way for automation of anaesthesia.
Introduction
Although there is no agreement on its specific definition, general anaesthesia can be defined as a drug-induced, reversible condition composed of the behavioral states of hypnosis, analgesia/antinociception, and immobility [17, 109] . Hypnosis is a state related to unconsciousness and disability of post operative recall of events that occurred during surgery. Analgesia is the suppression of pain (a conscious experience [10] ), and antinociception is the suppression of response to potentially damaging stimuli (pain is not necessarily implied [73] ), both of which can be achieved through administered opioids. Immobility is the lack of movement in response to noxious stimulation. During general anaesthesia, the stability of the autonomic, cardiovascular, respiratory, and thermoregulatory systems must be preserved [17, 25] .
Modern general anaesthetic techniques typically involve the combined use of a hypnotic drug, an opioid with or without a muscle relaxant [109] to achieve a desirable anaesthetic level. In common practice, the anaesthesiologist first evaluates the patient based on a variety of considerations such as age, weight and disease, provides a recommended drug dosage, and subsequently adjusts the dose based on the observed result [43] .
Automation of anaesthesia may offer a number of advantages by improving both the safety of patients and cost-efficiency. It may reduce the risk of awareness and adverse outcomes during anaesthesia, as well as reduce the healthcare cost due to drugs, devices and recovery time. However, such an automation system has yet to be realized due to a manifold of challenges. This paper is aimed at reviewing some challenges faced in the automation of anaesthesia. The current progress in overcoming these challenges will also be discussed. Major focus will be given to intravenous rather than inhaled anaesthesia. It is beyond the scope of this paper to include all relevant publications, hence some contributions may have been overlooked. This paper is organized as follows: Sect. 2 describes the standard pharmacokinetic/pharmacodynamic models describing the drugs used in anaesthesia. Section 3 discusses the challenges faced which include model uncertainty, controlled variable, closed-loop application and dependability. Finally, Sect. 4 draws some concluding remarks.
Standard pharmacokinetic/pharmacodynamic model
The pharmacokinetic/pharmacodynamic (PK/PD) model is a standard model used to describe the dose-effect relationship of drugs in the human body. PK describes the drug concentration-time course in body fluids (plasma) resulting from the administrated dose while PD relates the resulting concentration to the observed effect [24] .
There are two main forms of PK models: the physiological model and compartmental model. A physiological PK model analyzes volumes and clearances for each organ in the body and combines it into a physiologically and anatomically accurate model of the entire body. However, this model is mathematically cumbersome and does not offer better prediction of plasma drug concentration [93] .
The PK of most anaesthetic drugs can be described using a three-compartment mammillary model (Fig. 1 ). In this model, a drug with infusion rate u is administered into the central compartment (plasma) V 1 . The drug is further distributed to V 2 (rapid peripheral compartment) and V 3 (slow peripheral compartment). k ij is the drug transfer rate constant from compartment i to compartment j while k 10 is the elimination rate constant of the drug.
To compensate the time lag between observed effect and plasma concentration, an additional compartment, i.e., the effect compartment is introduced. The effect compartment model [95] links the plasma concentration to the effect concentration with a first order differential equation
where C p is the plasma concentration, C e is the effect compartment concentration and k e0 is the rate constant of drug elimination from the effect compartment. The PD model is governed by a static non-linear (sigmoidal) Hill equation [41] . The relationship between effect and the effect compartment concentration can be described using this equation:
where E is the effect, E 0 is the baseline effect, E max is the maximum effect (drug's efficacy), and EC 50 is the concentration that produces 50 % of the maximum effect (drug potency). c is the Hill coefficient that describes the sigmoidicity and steepness of the concentration-effect curve.
The standard PK/PD model is well-accepted for singleinput single output (SISO) systems. However, the model has a few significant drawbacks, especially in realizing multivariable control. Limitations of the conventional PK/ PD model will be discussed in the next section.
Challenges
It is generally accepted that closed-loop systems for anaesthesia are more difficult to design and implement than other challenging fields like the aviation industry [2, 32] . The operational domain of anaesthesia is a dynamic and complex environment [49] . The stakes are high because even for elective surgery in healthy patients, there is a life-threatening risk. During any event in the operating room, immediate action must be taken and cannot be delayed or aborted. Previous decisions and actions will have a large influence on future decisions [82] .
In this section, several main challenges in automation of anaesthesia are discussed, namely model uncertainty, controlled variable, closed-loop application, and dependability. Some of the current developments in overcoming these challenges are also included.
Model uncertainty
A major challenge in the automation of anaesthesia is the variability among patients. This variability can occur as a result of patient physiology (age, gender, disease, etc.), variations in PK processes (rate of absorption, distribution, metabolism, and excretion, etc.), and differences in PD (sensitivity of receptor, upregulation and downregulation, etc.) [94] . Bibian et al. [7, 8] made an attempt to express patient variability into a quantified system uncertainty. They concluded that no single general purpose controller can be designed for the whole adult population and a wide range of drug administration-it cannot be robustly stable while achieving adequate performance. Instead, reduction of uncertainty can be achieved by simple and practical methods such as limiting the validity of the models to a particular operating condition (type of administration, control range), or population subset (age group).
One of the early approaches to account for patient variability is the construction of population PK/PD models. Population studies were done to identify and integrate significant covariates into model parameters. For example, Minto et al. [75, 76] have incorporated age and lean body mass (LBM) into the remifentanil PK model. Schnider et al. [90, 91] have incorporated age, total weight, and height into the propofol PK model.
However, the present population PK/PD models have several shortcomings. First, there is no PK/PD model being accepted as the standard model.Various PK and PD models for propofol have been proposed in the literature, including those proposed by Schnider [90, 91] , Marsh [69] , Björns-son [11] , Schuttler [92] and Kataria (paediatric) [47] . The estimated parameters differ significantly between models, resulting in a considerable difference in the predicted drug dosage [1, 9, 22] . Among them, the Schnider and Marsh models are widely used in current target controlled infusion (TCI) practice. Failure to recognise the differences between these models may result in overdosage or underdosage of drug [1] .
Second, there is still room to search for other significant factors in the model. For instance, a linear relation is found between age and EC 50 [70] . Cardiac output (CO) [3, 108] and administration mode (bolus or infusion) [91] were also found to influence the time and dose required for propofol anaesthesia. However, some of these factors could not be incorporated into the standard compartmental model [83] due to oversimplified assumptions and structure limitation.
Third, drug interaction may occur when they are used in combination. These interactions may be additive, synergistic, or antagonistic [40, 110] . A common combination of drugs, i.e. propofol and remifentanil, was found to have a synergistic interaction pharmacodynamically [15, 48, 74] .
The interaction in PD has been investigated and quantified in many studies [13, 15, 77] . Since anaesthesia has multimodal endpoints, a single PD model may not be sufficient to describe the adequacy of anaesthesia [74] . Different PD models should be used to describe hypnotic and analgesic endpoints [61] .
Interaction may occur also in PK. An investigation of the effect of remifentanil on plasma propofol concentration has found that remifentanil reduces hepatic clearance of propofol and significantly increases the propofol C p [112] .
Besides variability, external disturbances such as surgical stimulation and blood loss are inevitable during the surgical procedure. These disturbances also contribute to the model uncertainty. Resolving conflict between achieving robustness against variability and rejecting surgical disturbance is another demanding problem [34] .
Recently, ''individualized'' model has become an alternative option for closed-loop control of anaesthesia. In this model, parameters are identified on-line using initial clinical data. These individualized parameters may help to improve the model's prediction capability and promote optimal control in drug administration [86] . Several individualized controllers [30, 86, 87, 101] have been proposed in the literature.
Nevertheless, the data collected from the operating room is often limited and has little excitation in the input signals. These are critical challenges to parameter identification in real-time. One strategy is to simplify the model by reducing the number of parameters that need to be estimated.
Simplification of the dose-response model has been proposed in various studies. Hahn et al. [35] proposed a direct dynamic dose-response model where the multicompartmental PK model is replaced by simple first-order dynamics. Tan et al. [103] proposed a simplified Wiener model structure suitable for multi-input multi-output (MIMO) systems but with no further evaluation. Recently, a reduced MIMO Wiener model has been presented by Silva et al. [97] . The model describes the joint effect of propofol and remifentanil on BIS and state entropy, and shows a very good fitting to the data. However, until now, there is no satisfactory MIMO model that considers both hypnosis and haemodynamic parameters.
Controlled variables
Conventionally, the anaesthesiologist assesses depth of anaesthesia by observing clinical signs such as heart rate, blood pressure, ocular signs, lacrimation and sweat [19, 99] . However, clinical signs alone are not reliable for measuring anaesthetic adequacy [19, 89] . They are subjective, discontinuous [45] and vary considerably depending on patient, disease, drug and surgical technique [89] . Continuous quantitative measurement can not only improve the quality of assessment, but is also essential as a controlled variable in a closed-loop control system.
Quantitative measurement of muscle relaxation can be easily assessed by peripheral neurostimulation and recording of muscle response. However, methods to measure the other two main components of anaesthesia, namely hypnosis and antinociception are still under development.
One such approach is through analysis of the electroencephalogram (EEG) [68] .
EEG is the recording of electrical activity in the cerebral cortex produced by summation of inhibitory and excitatory postsynaptic potentials [66] . Anaesthesia changes the frequency and amplitude of EEG waveforms depending on the type and dose of drug. For example, initially at low concentration, propofol triggers EEG activation by increasing the high frequency activity. This is followed by a depression effect where the middle frequency (5-20 Hz) activity increases while high frequency activity decreases. As the concentration continues to increase, the activity shifts from middle frequencies to low frequencies. During deep hypnosis, burst suppression pattern (BSP) is observed [51, 66] .
Over the last two decades, a number of EEG-based monitors have been developed. These include the Bispectral Index (BIS TM ) monitor, the Narcotrend TM monitor, Cerebral state monitor (CSM TM ) and M-entropy TM module [78] . Generally, these monitors were developed by searching for a computational parameter capable of relating changes in the EEG signal characteristics to the druginduced changes during anaesthesia [50] .
However, several factors affect the reliability of EEGderived indices. These include influence of electromyographic (EMG) activity [5, 14, 18] , electrical or mechanical artifacts from medical devices [23, 38, 81] , time delay [113] , specific clinical conditions such as hypovolaemia, hypotension, cerebral ischaemia, hypoglycaemia and hypothermia [23] , inter-individual variability of baseline EEG characteristics [68, 111] and types of drugs [44] . In addition, opioids may interfere with the EEG-signal during administration of the hypnotic agent [26, 50, 63, 67, 84, 88] thus rendering the reliability of indices during multidrug administration questionable.
Due to the incomplete understanding of the mechanisms of general anaesthesia, attempts to monitor anaesthetic depth have been restricted to heuristic approaches [54] . A better knowledge of the theory and neurophysiological facts of anaesthesia may benefit the development of a depth of anaesthesia monitor.
Based on the theory of mammalian cortical electrorhythmogenesis [12] , Liley et al. [55] have demonstrated the possibility of dissociating the effects of propofol and remifentanil on the EEG. Two indices, i.e. the cortical state (CS) and cortical input (CI), have been proposed to measure the individual effects of propofol and remifentanil on brain electrical activity. Each index is independent from the other, thus enabling separate monitoring of hypnotic and analgesic drug actions.
Recently, a theory-driven index, the Pertubational Complexity Index (PCI) [21] has been developed to quantify loss of consciousness (LOC) using Transcranial Magnetic Stimulation combined with high density electroencephalography (TMS/EEG). PCI has shown a clear cut distinction between consciousness and unconsciousness in single individuals during wakefulness, sleep, and anaesthesia (midazolam, xenon, and propofol), as well as in patients who had emerged from coma [21, 85] . The theory behind this is that consciousness depends not so much on the level of brain activity but rather on the brain's capacity to sustain complex patterns of internal communication, i.e., integrate information [72, 105, 106] . In other words, during loss of consciousness, the thalamocortical system loses its ability to interact as a single entity (integration) and discriminate among a large repertoire of available states (information).
Other examples of advanced EEG analysis that may contribute to the problem include Granger causality [28, 79] , symbolic transfer entropy [52] and permutation entropy [46] [68] . Nonetheless, refinement is necessary for the techniques to be applied in daily practice.
As mentioned earlier, anaesthesia has multimodal endpoints. Several analgesia indices based on different modalities have been developed to quantify the analgesic state (nociceptive-antinociceptive balance). These include the surgical pleth index (SPI TM ) [42] based on photoplethysmographic pulse wave amplitude (PPGA) and normalized heart beat interval (HBI), the Analgoscore TM [37] based on mean arterial pressure (MAP) and heart rate, and the analgesia nociception index (ANI TM ) [59] monitor based on heart rate variability. Skin conductance variability is used by the Med-Storm TM monitor [102] to quantify analgesia. The wavelet transform cardiorespiratory coherence (WTCRC) algorithm [16] , which is based on respiratory and heart rates, has been introduced. Another index which does not involve physiological measurements is the Noxious Stimulation Response Index (NSRI) [61] . Generally, analgesia monitors have not been as well established as hypnotic-depth monitors. Further investigation and validation of these indices is required.
In view of the complexity of anaesthetic effects, it is desirable to have well-defined anaesthesia endpoints. Each endpoint should be monitored separately and specifically [68] . Validation should be done based on specific drugs. In addition, understanding of the underlying mechanism may benefit the development of measuring the relevant endpoints. Substantial insight can be gained by studying the relation between natural sleep and general anaesthesia [17, 107] .
Closed-loop application
Apart from model uncertainties and lack of reliable controlled variables, closed-loop control of anaesthesia is complicated by the nature of its nonlinear, time-varying delay and multiple control objectives.
Human response to anaesthesia effect is nonlinear and time varying. While many design techniques for linear time-invariant (LTI) systems have been well-established, there are still many open problems for feedback control of nonlinear and time varying system. In addition, throughout the surgical procedure, it is not uncommon to have shifting, or even conflicting goals, which depend on the changes in the patient's situation [49] .
Typically, there are three main phases in general anaesthesia: induction, maintenance and emergence. Each phase has a different control objective. During the induction phase, the clinical objective is to have a fast transition to the setpoint with minimal overshoot and undershoot and short settling time. However, although large boluses of drugs shorten the duration, this will result in a high overshoot [100] . This sudden onset of unconsciousness may cause depression of airway, respiratory and cardiovascular reflexes. Opioids and muscle relaxants are sometimes administered to assist insertion of an endotracheal tube [6] . During the maintenance phase, hypnotic agents and opioids continue to be administered to maintain adequate anaesthesia. The two main challenges in this phase are large inter-patient variability and disturbance (e.g. surgical stimulation, blood loss) throughout the procedure. The emergence phase is simply achieved by terminating the drug administration. A short emergence duration is favourable. The length of this duration is influenced by the dosing history during the maintenance phase.
One possible approach to control such models is the use of intelligent control. It offers the possibility of control without the need for a precise mathematical model of the process.
Linkens et al. [57] were among the first to exploit multivariable closed-loop control of anaesthesia with intelligent control. A model consisting of isoflurane and atracurium as inputs, and MAP and evoked EMG as outputs is controlled by the self-organizing fuzzy logic controller (SOFLC). An attractive feature of SOFLC is its ability to generate nonlinear rules suitable for a nonlinear dynamic system.
To improve the SOFLC algorithm, Shieh et al. [96] further proposed the use of decomposition of multivariable self-organizing fuzzy logic structures into a set of onedimensional systems. The simulation result shows feasibility in control. Lu et al. [60] on the other hand developed a new Self-Organizing Fuzzy Logic Control algorithm (SOFLC-DPI) with the ability of on-line learning, which ensures a fast tracking performance and good set-point tracking ability.
Back in 1998, a closed-loop system for simultaneous control of anaesthetic and analgesic drugs was designed by Zhang et al. [114] . The interaction model of propofol and fentanyl is determined by unweighted least squares nonlinear regression analysis. A look-up table for optimal combination concentration for both drugs and awakening concentration for both drugs is built. The system then utilizes artificial neural network for classification of depth of anaesthesia and adjusts the set-point concentrations using a fuzzy-logic controller.
A fuzzy-neuro controller was also developed by Nunes et al. [80] and Mahfouf et al. [65] for simultaneous regulation of propofol and remifentanil. First, depth of anaesthesia is classified using fuzzy relational classifier (FRC). Second, a hybrid Takagi-Sugeno Kang fuzzy model is developed to represent the PD interaction of propofol and remifentanil. The resulting model relates heart rate, systolic arterial pressure and the auditory evoked potential (AEP) features with the effect compartment concentrations of both drugs. The FRC, Takagi-Sugeno Kang pharmacodynamic models and multivariable fuzzy controller are then combined to form a closed-loop control system for anaesthesia.
Despite challenges, model-based control has shown a lot of progress in closing the loop of anaesthesia. One of the attractive model-based advanced control schemes is the model predictive control (MPC). MPC enables incorporation of constraints on inputs, input rates and outputs in a systematic manner [20] . However, MPC relies on the availability of models. Hence, it is important to provide accurate information to the controller in order to maximize its performance.
Mahfouf et al. [64] developed a multivariable generalized predictive controller (GPC) in which simultaneous control and on-line identification of muscle relaxation and MAP was made. The GPC was compared to the previous multivariable SOFLC mentioned. The result shows that when the system's mathematical model is known and is structurally accurate, the multivariable GPC is found to be more robust than SOFLC.
Simanski et al. [98] developed a system for the control of neuromuscular blockade and hypnosis using modelbased adaptive GPC. As the interaction between muscle relaxation and hypnosis is insignificant, a decentralized MIMO control system is applied.
Furutani et al. [30] derived an analgesia index from pulse rate and Entropy Difference (ED) and constructed a model predictive control system for hypnosis and analgesia using BIS and the analgesia index as output. The system has an identification function of individual PD parameters and dead times, obtained from the first 10 min of anaesthesia. However, improvement on the identification of individual parameters is necessary.
Ionescu et al. [43] developed an extended prediction self-adaptive control (EPSAC)-MPC to control BIS and electro-myogram-based surrogate variable by manipulating propofol and remifentanil. Simulation result shows that the multivariable predictive control algorithm proposed is feasible.
In recent years, a few clinical studies of closed-loop control have been done and have shown to outperform manual administration of drugs [33, 36, 39, 58] . However, these controllers were designed based on subjective clinical experience rather than optimization of the process. Further research is certainly required to obtain the true benefits of automation.
Dependability
The dependability of a system is defined as its ability to deliver service that can justifiably be trusted [4, 62] . In the case of anaesthesia control, safety and reliability are two important attributes of dependability. Safety is the ability of the system to operate without catastrophic failure, while reliability is the ability to deliver services as specified. These attributes are limited by the presence of faults, which may lead to system failure.
In anaesthesia control, all measurable outputs of anaesthesia are based on physiological signals which are potentially corrupted by artifacts [31] . Artifacts may arise due to noise in measurement signals, detection-location changing and disconnection of sensors from the patient. Such artifacts may lead to wrong control decisions and can be harmful to the patient. Other possible faults include actuator failure, algorithm failure, disconnection of system, etc.
Fukui et al. [29] used the knowledge-based approach of ''if, then'' statement for fault detection. Linkens et al. [56] proposed a fault-detection-isolation-accommodation (FIDA) scheme where fault is detected by comparing the prediction error (residual) with a preset threshold. Once the source of fault has been identified, accommodation will be provided according to the type of fault. Mason et al. [71] employed a three-term median filter to detect artifacts and ''pausing'' the controller during artifacts. Lemos et al. [53] proposed a Bayesian inference and predictive filter (a combination of Bayesian decision and a three-point median filter followed by a fifth-order low pass filter) to detect sensor fault and reconstruct signal during the fault.
Frei et al. [27] introduced a supervisory system embedded in the real-time platform to detect sensor failures and/or other abnormal operation. An observer based state feedback controller was used for artifact-tolerant control. The method was tested during clinical evaluation and was able to suppress artifacts successfully. Tao et al. [104] proposed a fault tolerant system with an extended state observer and a switching strategy. The extended state observer (ESO) is used as a fault detection device and is able to deal with nonlinearity introduced by BIS. If the observer bias was larger than the threshold, the observer would become an open-loop observer with the function of short-time prediction.
Fault occurrence (especially artifacts) is rather common in the operating theatre. To automatize anaesthesia control, the controller must be able to perform satisfactorily in the presence of faults. While fault tolerance tries to reduce the effect of faults in the event of failures, fault prevention may be useful to reduce the probability of fault before the system becomes operational.
Dependability of the system can be further improved through development of warning systems. Furthermore, input of other physiological measurements together with the measured or calculated drug concentrations will help to improve the performance of the system. Dependence on a single measure, like the BIS, as the sole input to the controller, is undesirable. All these should be in place before an automated approach to anaesthetic delivery can be considered. In any case, human intervention must always be allowed in situations where the system appears to be delivering the drugs at rates higher or lower than expected.
Conclusion
Regulation of anaesthesia is indeed a multivariable problem. Control of anaesthesia cannot be done based on feedback of a single measurable output. Ideally, it is desirable to develop control strategies to regulate all the necessary anaesthesia components simultaneously with the balanced use of various drugs. However, realization of close loop control is hindered by some significant challenges.
In this paper, a review on automation of anaesthesia is given. In particular, several challenges are discussed: model uncertainty, controlled variables, closed-loop application and dependability. The complexity undoubtedly presents a big challenge to automatized anaesthesia. Such a device may not be ready in less than 20-30 years. Nonetheless, numerous advances have been witnessed in these recent years. The increasingly reliable measurement, robust and adaptive controller, and better fault tolerance strategy are paving the way for automation of anaesthesia.
